©The Author(s) 2025.
World J Gastrointest Oncol. Sep 15, 2025; 17(9): 109378
Published online Sep 15, 2025. doi: 10.4251/wjgo.v17.i9.109378
Published online Sep 15, 2025. doi: 10.4251/wjgo.v17.i9.109378
Figure 2 Effects of rapamycin on migration and invasion of HUTU 80 cells.
A: Detection of the effect of rapamycin (RAPA) on cell migration ability through a wound healing assay; B: Assessment of the influence of RAPA on cell invasion capabilities using Transwell assay; C: Statistical chart of the cell migration ratio; D: Statistical chart of cell invasion ability; E: Quantitative polymerase chain reaction was used to evaluate the messenger RNA expression level of MMP2. Data are presented as the mean ± SD (n = 3). aP < 0.05. bP < 0.01. cP < 0.001. MMP: Matrix metalloproteinase; RAPA: Rapamycin.
- Citation: Pu BP, Wang PH, Guo KK, Liu C, Chen SR, Li XM, Chen SM, Zeng XZ, Gao C. Rapamycin suppresses small bowel adenocarcinoma HUTU 80 cells proliferation by inhibiting hypoxia-inducible factor-1α mediated metabolic reprogramming. World J Gastrointest Oncol 2025; 17(9): 109378
- URL: https://www.wjgnet.com/1948-5204/full/v17/i9/109378.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i9.109378